SEC Form 4 · accession 0000882104-15-000088
PDL BIOPHARMA, INC. · PDLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter S Garcia
Officer — Vice President, CFO
Period of report
Dec 14, 2015
Accepted (ET)
Dec 16, 2015 · 6:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882104
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 14, 2015 | P | 10,000 | $3.4245 | A | 121,041 | D | |
| Common stock | Dec 15, 2015 | P | 5,000 | $3.6399 | A | 126,041 | D |
Table II — derivative securities
No Table II lines on this filing.